This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Methylene Blue Does Not Improve Vasoplegia After Left Ventricular Assist Device Implantation

Friday, April 9, 2021

Submitted by


Source Name: The Annals of Thoracic Surgery


Amit Saha, MD, Douglas L. Jennings, PharmD, Yuming Ning, PhD, Paul Kurlansky, MD, Andrea N. Miltiades, MD, Jessica L. Spellman, MD, Joseph Sanchez, MD, Melana Yuzefpolskaya, MD, Paolo C. Colombo, MD, Hiroo Takayama, MD, PhD, Yoshifumi Naka, MD, PhD, and Koji Takeda, MD, PhD
This investigation studied the effectiveness of methylene blue (MB) for vasoplegia in LVAD recipients and found that clinical outcomes did not improve after LVAD implantation.

Add comment

Log in or register to post comments